Pharmaron Beijing Co., Ltd. Stock

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 18:00:00 2024-05-16 EDT 5-day change 1st Jan Change
22.22 CNY +0.05% Intraday chart for Pharmaron Beijing Co., Ltd. +2.35% -23.33%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 12.75B 1.76B 2.4B Sales 2025 * 14.81B 2.05B 2.79B Capitalization 36.03B 4.99B 6.79B
Net income 2024 * 1.6B 221M 301M Net income 2025 * 2.16B 299M 407M EV / Sales 2024 * 3.07 x
Net Debt 2024 * 3.16B 437M 595M Net Debt 2025 * 2.74B 380M 517M EV / Sales 2025 * 2.62 x
P/E ratio 2024 *
23.9 x
P/E ratio 2025 *
18.8 x
Employees -
Yield 2024 *
0.97%
Yield 2025 *
1.29%
Free-Float 47.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.05%
1 week+2.35%
Current month+12.51%
1 month+16.95%
3 months+5.46%
6 months-35.01%
Current year-23.33%
More quotes
1 week
21.63
Extreme 21.63
23.75
1 month
17.88
Extreme 17.88
23.75
Current year
17.88
Extreme 17.88
28.90
1 year
17.88
Extreme 17.88
37.00
3 years
17.88
Extreme 17.88
108.71
5 years
14.22
Extreme 14.2222
108.71
10 years
4.08
Extreme 4.0844
108.71
More quotes
Managers TitleAgeSince
Founder 55 04-06-30
Founder 57 04-06-30
Chief Executive Officer 60 04-06-30
Members of the board TitleAgeSince
Director/Board Member 60 19-08-14
Director/Board Member 51 16-10-26
Chief Executive Officer 60 04-06-30
More insiders
Date Price Change Volume
24-05-17 22.22 +0.05% 20,646,600
24-05-16 22.21 -0.13% 25,333,610
24-05-15 22.24 -0.98% 30,730,940
24-05-14 22.46 +1.13% 36,477,220
24-05-13 22.21 +2.30% 60,909,850

End-of-day quote Shenzhen S.E., May 16, 2024

More quotes
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows: - laboratory services (61.3%); - development and production of chemical processes and formulations (23.5%); - clinical research services (12.8%); - other (2.4%); Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
22.22 CNY
Average target price
24.15 CNY
Spread / Average Target
+8.67%
Consensus
  1. Stock Market
  2. Equities
  3. 300759 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW